At the American Association for the Study of Liver Diseases (AASLD) annual meeting, a session highlighted new guidance on ...

WASHINGTON -- Semaglutide (Wegovy) improved liver inflammation and fibrosis in patients with metabolic dysfunction-associated ...

Robbie Williams has spoken publicly about using injectable weight loss medicines for several years. He has credited them with ...

This article was reviewed by Darragh O’Carroll, MD. Semaglutide Side Effects: What to Know Key takeaways: Common semaglutide ...

The race to develop the next generation of weight loss drugs has taken an interesting new turn. In recent research, Eli Lilly ...

At AHA 2025, data from the SCORE-HF study (NCT07141914) were presented, evaluating Novo Nordisk’s semaglutide 2.4mg and its ...

The prevalence of overweight and obesity has reached pandemic proportions, affecting more than 1 billion people worldwide; it ...

Semaglutide therapy was associated with higher likelihood of passing low-risk cardiovascular thresholds among patients with ...

New research from the Technical University of Munich and Harvard Medical School reveals that popular GLP-1-based drugs, ...

Oral semaglutide 25 mg was associated with improved glycemic parameters and cardiovascular risk across weight loss categories ...

Novo Nordisk will strengthen its oral semaglutide portfolio led by Rybelsus while cutting Wegovy injection prices by up to 37 ...

Zydus Lifesciences Ltd and Torrent Pharmaceuticals Ltd are preparing to enter the fast-growing market for Semaglutide — a ...